Loading…
Angiotensin II Activates Na+-Independent Cl--HCO3- Exchange in Ventricular Myocardium
The effect of angiotensin II (Ang II) on the activity of the cardiac Na Cl3 exchanger (anionic exchanger [AE]) was explored in cat papillary muscles. pHi was measured by epifluorescence with BCECF-AM. Ang II (500 nmol/L) induced a 5-(N-ethyl-N-isopropyl)amiloride-sensitive increase in pHi in the abs...
Saved in:
Published in: | Circulation research 1998-03, Vol.82 (4), p.473-481 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | 481 |
container_issue | 4 |
container_start_page | 473 |
container_title | Circulation research |
container_volume | 82 |
creator | de Hurtado, Maria C. Camilion Alvarez, Bernardo V Perez, Nestor G Ennis, Irene L Cingolani, Horacio E |
description | The effect of angiotensin II (Ang II) on the activity of the cardiac Na Cl3 exchanger (anionic exchanger [AE]) was explored in cat papillary muscles. pHi was measured by epifluorescence with BCECF-AM. Ang II (500 nmol/L) induced a 5-(N-ethyl-N-isopropyl)amiloride-sensitive increase in pHi in the absence of external HCO3 (HEPES buffer), consistent with its stimulatory action on Na exchange (NHE). This alkalinizing effect was not detected in the presence of a CO2-HCO3 buffer (pH (i) 7.07 +/- 0.02 and 7.08 +/- 0.02 before and after Ang II, respectively; n=17). Moreover, in Na HCO3 medium, in which neither NHE nor Na3 cotransport are acting, Ang II decreased pHi, and this effect was canceled by previous treatment with SITS. These findings suggested that the Ang II-induced activation of NHE was masked, in the presence of the physiological buffer, by a HCO3 acidifying mechanism, probably the AE. This hypothesis was confirmed on papillary muscles bathed with HCO3 buffer that were first exposed to 1 [micro sign]mol/L S20787, a specific inhibitor of AE activity in cardiac tissue, and then to 500 nmol/L Ang II (n=4). Under this condition, Ang II increased pHi from 7.05 +/- 0.05 to 7.22 +/- 0.05 (P |
doi_str_mv | 10.1161/01.res.82.4.473 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_79733083</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>79733083</sourcerecordid><originalsourceid>FETCH-LOGICAL-h3149-da4f6ca37cc4d5485bf9a691db48da3364c3e6e187b42e1b6848e76035e001813</originalsourceid><addsrcrecordid>eNo9kDFPwzAQhS0EKqUwMyFlQCzIwY6dxB6rqtBIhS6UNXKcSxtwk2InlP57XLViuTvd--6k9xC6pSSkNKFPhIYWXCiikIc8ZWdoSOOIYx6n9BwNCSESp4yRS3Tl3CchlLNIDtBAxiRJiRii5bhZ1W0HjaubIMuCse7qH9WBC97UI86aErbgS9MFE4PxbLJgOJj-6rVqVhD4kw8v2Vr3Rtngdd9qZcu631yji0oZBzenPkLL5-n7ZIbni5dsMp7jNaNc4lLxKtGKpVrzMuYiLiqpEknLgotSMZZwzSABKtKCR0CLRHABaUJYDN6KoGyEHo5_t7b97sF1-aZ2GoxRDbS9y1N5MC-YB-9OYF9soMy3tt4ou89POXj9_qQrp5WprGp07f6xiEoupfQYP2K71nRg3Zfpd2DzNSjTrXOfNmGERphKKfwkCT6sJPsDbOl6BA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>79733083</pqid></control><display><type>article</type><title>Angiotensin II Activates Na+-Independent Cl--HCO3- Exchange in Ventricular Myocardium</title><source>Freely Accessible Science Journals</source><creator>de Hurtado, Maria C. Camilion ; Alvarez, Bernardo V ; Perez, Nestor G ; Ennis, Irene L ; Cingolani, Horacio E</creator><creatorcontrib>de Hurtado, Maria C. Camilion ; Alvarez, Bernardo V ; Perez, Nestor G ; Ennis, Irene L ; Cingolani, Horacio E</creatorcontrib><description>The effect of angiotensin II (Ang II) on the activity of the cardiac Na Cl3 exchanger (anionic exchanger [AE]) was explored in cat papillary muscles. pHi was measured by epifluorescence with BCECF-AM. Ang II (500 nmol/L) induced a 5-(N-ethyl-N-isopropyl)amiloride-sensitive increase in pHi in the absence of external HCO3 (HEPES buffer), consistent with its stimulatory action on Na exchange (NHE). This alkalinizing effect was not detected in the presence of a CO2-HCO3 buffer (pH (i) 7.07 +/- 0.02 and 7.08 +/- 0.02 before and after Ang II, respectively; n=17). Moreover, in Na HCO3 medium, in which neither NHE nor Na3 cotransport are acting, Ang II decreased pHi, and this effect was canceled by previous treatment with SITS. These findings suggested that the Ang II-induced activation of NHE was masked, in the presence of the physiological buffer, by a HCO3 acidifying mechanism, probably the AE. This hypothesis was confirmed on papillary muscles bathed with HCO3 buffer that were first exposed to 1 [micro sign]mol/L S20787, a specific inhibitor of AE activity in cardiac tissue, and then to 500 nmol/L Ang II (n=4). Under this condition, Ang II increased pHi from 7.05 +/- 0.05 to 7.22 +/- 0.05 (P<.05). The effect of Ang II on AE activity was further explored by measuring the velocity of myocardial pHi recovery after the imposition of an intracellular alkali load in a HCO3 solution either with or without Ang II. The rate of myocardial pHi recovery was doubled in the presence of Ang II, suggesting a stimulatory effect on AE. The enhancement of the activity of this exchanger by Ang II was also detected when the AE activity was reversed by the removal of extracellular Cl in a Na solution. Under this condition, the rate of intracellular alkalinization increased from 0.053 +/- 0.016 to 0.108 +/- 0.026 pH unit/min (n=6, P<.05) in the presence of Ang II. This effect was canceled either by the presence of the AT1 receptor antagonist, losartan, or by the previous inhibition of protein kinase C with chelerythrine or calphostin C. The above results allow us to conclude that Ang II, in addition to its stimulatory effect on alkaline loading mechanisms, activates the AE in ventricular myocardium and that the latter effect is mediated by a protein kinase C-dependent regulatory pathway linked to the AT1 receptors. (Circ Res. 1998;82:473-481.)</description><identifier>ISSN: 0009-7330</identifier><identifier>EISSN: 1524-4571</identifier><identifier>DOI: 10.1161/01.res.82.4.473</identifier><identifier>PMID: 9506708</identifier><identifier>CODEN: CIRUAL</identifier><language>eng</language><publisher>Hagerstown, MD: American Heart Association, Inc</publisher><subject>Alkaloids ; Amiloride - analogs & derivatives ; Amiloride - pharmacology ; Angiotensin II - physiology ; Angiotensin Receptor Antagonists ; Animals ; Antiporters - metabolism ; Benzophenanthridines ; Bicarbonates - metabolism ; Biological and medical sciences ; Cats ; Chloride-Bicarbonate Antiporters ; Chlorides - metabolism ; Enzyme Inhibitors - pharmacology ; Fundamental and applied biological sciences. Psychology ; Heart ; Heart Ventricles - metabolism ; Hydrogen-Ion Concentration ; In Vitro Techniques ; Losartan - pharmacology ; Myocardium - metabolism ; Phenanthridines - pharmacology ; Protein Kinase C - antagonists & inhibitors ; Receptor, Angiotensin, Type 1 ; Receptor, Angiotensin, Type 2 ; Signal Transduction ; Sodium - metabolism ; Sodium-Hydrogen Exchangers - antagonists & inhibitors ; Vertebrates: cardiovascular system</subject><ispartof>Circulation research, 1998-03, Vol.82 (4), p.473-481</ispartof><rights>1998 American Heart Association, Inc.</rights><rights>1998 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2194999$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9506708$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>de Hurtado, Maria C. Camilion</creatorcontrib><creatorcontrib>Alvarez, Bernardo V</creatorcontrib><creatorcontrib>Perez, Nestor G</creatorcontrib><creatorcontrib>Ennis, Irene L</creatorcontrib><creatorcontrib>Cingolani, Horacio E</creatorcontrib><title>Angiotensin II Activates Na+-Independent Cl--HCO3- Exchange in Ventricular Myocardium</title><title>Circulation research</title><addtitle>Circ Res</addtitle><description>The effect of angiotensin II (Ang II) on the activity of the cardiac Na Cl3 exchanger (anionic exchanger [AE]) was explored in cat papillary muscles. pHi was measured by epifluorescence with BCECF-AM. Ang II (500 nmol/L) induced a 5-(N-ethyl-N-isopropyl)amiloride-sensitive increase in pHi in the absence of external HCO3 (HEPES buffer), consistent with its stimulatory action on Na exchange (NHE). This alkalinizing effect was not detected in the presence of a CO2-HCO3 buffer (pH (i) 7.07 +/- 0.02 and 7.08 +/- 0.02 before and after Ang II, respectively; n=17). Moreover, in Na HCO3 medium, in which neither NHE nor Na3 cotransport are acting, Ang II decreased pHi, and this effect was canceled by previous treatment with SITS. These findings suggested that the Ang II-induced activation of NHE was masked, in the presence of the physiological buffer, by a HCO3 acidifying mechanism, probably the AE. This hypothesis was confirmed on papillary muscles bathed with HCO3 buffer that were first exposed to 1 [micro sign]mol/L S20787, a specific inhibitor of AE activity in cardiac tissue, and then to 500 nmol/L Ang II (n=4). Under this condition, Ang II increased pHi from 7.05 +/- 0.05 to 7.22 +/- 0.05 (P<.05). The effect of Ang II on AE activity was further explored by measuring the velocity of myocardial pHi recovery after the imposition of an intracellular alkali load in a HCO3 solution either with or without Ang II. The rate of myocardial pHi recovery was doubled in the presence of Ang II, suggesting a stimulatory effect on AE. The enhancement of the activity of this exchanger by Ang II was also detected when the AE activity was reversed by the removal of extracellular Cl in a Na solution. Under this condition, the rate of intracellular alkalinization increased from 0.053 +/- 0.016 to 0.108 +/- 0.026 pH unit/min (n=6, P<.05) in the presence of Ang II. This effect was canceled either by the presence of the AT1 receptor antagonist, losartan, or by the previous inhibition of protein kinase C with chelerythrine or calphostin C. The above results allow us to conclude that Ang II, in addition to its stimulatory effect on alkaline loading mechanisms, activates the AE in ventricular myocardium and that the latter effect is mediated by a protein kinase C-dependent regulatory pathway linked to the AT1 receptors. (Circ Res. 1998;82:473-481.)</description><subject>Alkaloids</subject><subject>Amiloride - analogs & derivatives</subject><subject>Amiloride - pharmacology</subject><subject>Angiotensin II - physiology</subject><subject>Angiotensin Receptor Antagonists</subject><subject>Animals</subject><subject>Antiporters - metabolism</subject><subject>Benzophenanthridines</subject><subject>Bicarbonates - metabolism</subject><subject>Biological and medical sciences</subject><subject>Cats</subject><subject>Chloride-Bicarbonate Antiporters</subject><subject>Chlorides - metabolism</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Heart</subject><subject>Heart Ventricles - metabolism</subject><subject>Hydrogen-Ion Concentration</subject><subject>In Vitro Techniques</subject><subject>Losartan - pharmacology</subject><subject>Myocardium - metabolism</subject><subject>Phenanthridines - pharmacology</subject><subject>Protein Kinase C - antagonists & inhibitors</subject><subject>Receptor, Angiotensin, Type 1</subject><subject>Receptor, Angiotensin, Type 2</subject><subject>Signal Transduction</subject><subject>Sodium - metabolism</subject><subject>Sodium-Hydrogen Exchangers - antagonists & inhibitors</subject><subject>Vertebrates: cardiovascular system</subject><issn>0009-7330</issn><issn>1524-4571</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><recordid>eNo9kDFPwzAQhS0EKqUwMyFlQCzIwY6dxB6rqtBIhS6UNXKcSxtwk2InlP57XLViuTvd--6k9xC6pSSkNKFPhIYWXCiikIc8ZWdoSOOIYx6n9BwNCSESp4yRS3Tl3CchlLNIDtBAxiRJiRii5bhZ1W0HjaubIMuCse7qH9WBC97UI86aErbgS9MFE4PxbLJgOJj-6rVqVhD4kw8v2Vr3Rtngdd9qZcu631yji0oZBzenPkLL5-n7ZIbni5dsMp7jNaNc4lLxKtGKpVrzMuYiLiqpEknLgotSMZZwzSABKtKCR0CLRHABaUJYDN6KoGyEHo5_t7b97sF1-aZ2GoxRDbS9y1N5MC-YB-9OYF9soMy3tt4ou89POXj9_qQrp5WprGp07f6xiEoupfQYP2K71nRg3Zfpd2DzNSjTrXOfNmGERphKKfwkCT6sJPsDbOl6BA</recordid><startdate>19980309</startdate><enddate>19980309</enddate><creator>de Hurtado, Maria C. Camilion</creator><creator>Alvarez, Bernardo V</creator><creator>Perez, Nestor G</creator><creator>Ennis, Irene L</creator><creator>Cingolani, Horacio E</creator><general>American Heart Association, Inc</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>19980309</creationdate><title>Angiotensin II Activates Na+-Independent Cl--HCO3- Exchange in Ventricular Myocardium</title><author>de Hurtado, Maria C. Camilion ; Alvarez, Bernardo V ; Perez, Nestor G ; Ennis, Irene L ; Cingolani, Horacio E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-h3149-da4f6ca37cc4d5485bf9a691db48da3364c3e6e187b42e1b6848e76035e001813</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Alkaloids</topic><topic>Amiloride - analogs & derivatives</topic><topic>Amiloride - pharmacology</topic><topic>Angiotensin II - physiology</topic><topic>Angiotensin Receptor Antagonists</topic><topic>Animals</topic><topic>Antiporters - metabolism</topic><topic>Benzophenanthridines</topic><topic>Bicarbonates - metabolism</topic><topic>Biological and medical sciences</topic><topic>Cats</topic><topic>Chloride-Bicarbonate Antiporters</topic><topic>Chlorides - metabolism</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Heart</topic><topic>Heart Ventricles - metabolism</topic><topic>Hydrogen-Ion Concentration</topic><topic>In Vitro Techniques</topic><topic>Losartan - pharmacology</topic><topic>Myocardium - metabolism</topic><topic>Phenanthridines - pharmacology</topic><topic>Protein Kinase C - antagonists & inhibitors</topic><topic>Receptor, Angiotensin, Type 1</topic><topic>Receptor, Angiotensin, Type 2</topic><topic>Signal Transduction</topic><topic>Sodium - metabolism</topic><topic>Sodium-Hydrogen Exchangers - antagonists & inhibitors</topic><topic>Vertebrates: cardiovascular system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>de Hurtado, Maria C. Camilion</creatorcontrib><creatorcontrib>Alvarez, Bernardo V</creatorcontrib><creatorcontrib>Perez, Nestor G</creatorcontrib><creatorcontrib>Ennis, Irene L</creatorcontrib><creatorcontrib>Cingolani, Horacio E</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Circulation research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>de Hurtado, Maria C. Camilion</au><au>Alvarez, Bernardo V</au><au>Perez, Nestor G</au><au>Ennis, Irene L</au><au>Cingolani, Horacio E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Angiotensin II Activates Na+-Independent Cl--HCO3- Exchange in Ventricular Myocardium</atitle><jtitle>Circulation research</jtitle><addtitle>Circ Res</addtitle><date>1998-03-09</date><risdate>1998</risdate><volume>82</volume><issue>4</issue><spage>473</spage><epage>481</epage><pages>473-481</pages><issn>0009-7330</issn><eissn>1524-4571</eissn><coden>CIRUAL</coden><abstract>The effect of angiotensin II (Ang II) on the activity of the cardiac Na Cl3 exchanger (anionic exchanger [AE]) was explored in cat papillary muscles. pHi was measured by epifluorescence with BCECF-AM. Ang II (500 nmol/L) induced a 5-(N-ethyl-N-isopropyl)amiloride-sensitive increase in pHi in the absence of external HCO3 (HEPES buffer), consistent with its stimulatory action on Na exchange (NHE). This alkalinizing effect was not detected in the presence of a CO2-HCO3 buffer (pH (i) 7.07 +/- 0.02 and 7.08 +/- 0.02 before and after Ang II, respectively; n=17). Moreover, in Na HCO3 medium, in which neither NHE nor Na3 cotransport are acting, Ang II decreased pHi, and this effect was canceled by previous treatment with SITS. These findings suggested that the Ang II-induced activation of NHE was masked, in the presence of the physiological buffer, by a HCO3 acidifying mechanism, probably the AE. This hypothesis was confirmed on papillary muscles bathed with HCO3 buffer that were first exposed to 1 [micro sign]mol/L S20787, a specific inhibitor of AE activity in cardiac tissue, and then to 500 nmol/L Ang II (n=4). Under this condition, Ang II increased pHi from 7.05 +/- 0.05 to 7.22 +/- 0.05 (P<.05). The effect of Ang II on AE activity was further explored by measuring the velocity of myocardial pHi recovery after the imposition of an intracellular alkali load in a HCO3 solution either with or without Ang II. The rate of myocardial pHi recovery was doubled in the presence of Ang II, suggesting a stimulatory effect on AE. The enhancement of the activity of this exchanger by Ang II was also detected when the AE activity was reversed by the removal of extracellular Cl in a Na solution. Under this condition, the rate of intracellular alkalinization increased from 0.053 +/- 0.016 to 0.108 +/- 0.026 pH unit/min (n=6, P<.05) in the presence of Ang II. This effect was canceled either by the presence of the AT1 receptor antagonist, losartan, or by the previous inhibition of protein kinase C with chelerythrine or calphostin C. The above results allow us to conclude that Ang II, in addition to its stimulatory effect on alkaline loading mechanisms, activates the AE in ventricular myocardium and that the latter effect is mediated by a protein kinase C-dependent regulatory pathway linked to the AT1 receptors. (Circ Res. 1998;82:473-481.)</abstract><cop>Hagerstown, MD</cop><pub>American Heart Association, Inc</pub><pmid>9506708</pmid><doi>10.1161/01.res.82.4.473</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0009-7330 |
ispartof | Circulation research, 1998-03, Vol.82 (4), p.473-481 |
issn | 0009-7330 1524-4571 |
language | eng |
recordid | cdi_proquest_miscellaneous_79733083 |
source | Freely Accessible Science Journals |
subjects | Alkaloids Amiloride - analogs & derivatives Amiloride - pharmacology Angiotensin II - physiology Angiotensin Receptor Antagonists Animals Antiporters - metabolism Benzophenanthridines Bicarbonates - metabolism Biological and medical sciences Cats Chloride-Bicarbonate Antiporters Chlorides - metabolism Enzyme Inhibitors - pharmacology Fundamental and applied biological sciences. Psychology Heart Heart Ventricles - metabolism Hydrogen-Ion Concentration In Vitro Techniques Losartan - pharmacology Myocardium - metabolism Phenanthridines - pharmacology Protein Kinase C - antagonists & inhibitors Receptor, Angiotensin, Type 1 Receptor, Angiotensin, Type 2 Signal Transduction Sodium - metabolism Sodium-Hydrogen Exchangers - antagonists & inhibitors Vertebrates: cardiovascular system |
title | Angiotensin II Activates Na+-Independent Cl--HCO3- Exchange in Ventricular Myocardium |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T11%3A46%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Angiotensin%20II%20Activates%20Na+-Independent%20Cl--HCO3-%20Exchange%20in%20Ventricular%20Myocardium&rft.jtitle=Circulation%20research&rft.au=de%20Hurtado,%20Maria%20C.%20Camilion&rft.date=1998-03-09&rft.volume=82&rft.issue=4&rft.spage=473&rft.epage=481&rft.pages=473-481&rft.issn=0009-7330&rft.eissn=1524-4571&rft.coden=CIRUAL&rft_id=info:doi/10.1161/01.res.82.4.473&rft_dat=%3Cproquest_pubme%3E79733083%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-h3149-da4f6ca37cc4d5485bf9a691db48da3364c3e6e187b42e1b6848e76035e001813%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=79733083&rft_id=info:pmid/9506708&rfr_iscdi=true |